minoxidil has been researched along with Contact Dermatitis in 13 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 32-week, double-blind, placebo-controlled trial was conducted in 10 European centers to assess the efficacy and safety of 2% topical minoxidil solution for the treatment of androgenetic alopecia in women." | 9.07 | Use of topical minoxidil therapy for androgenetic alopecia in women. ( Jacobs, JP; Szpunar, CA; Warner, ML, 1993) |
| "Perhaps the most intriguing aspect of topical minoxidil is the fact that this drug can promote hair growth in two unrelated conditions: alopecia areata (AA) and androgenetic alopecia." | 9.06 | Topical minoxidil in extensive alopecia areata, including 3-year follow-up. ( Price, VH, 1987) |
| "A 32-week, double-blind, placebo-controlled trial was conducted in 10 European centers to assess the efficacy and safety of 2% topical minoxidil solution for the treatment of androgenetic alopecia in women." | 5.07 | Use of topical minoxidil therapy for androgenetic alopecia in women. ( Jacobs, JP; Szpunar, CA; Warner, ML, 1993) |
| "Perhaps the most intriguing aspect of topical minoxidil is the fact that this drug can promote hair growth in two unrelated conditions: alopecia areata (AA) and androgenetic alopecia." | 5.06 | Topical minoxidil in extensive alopecia areata, including 3-year follow-up. ( Price, VH, 1987) |
| "Alopecia areata is an asymptomatic, nonscarring hair loss with spontaneous remissions and exacerbations." | 2.38 | Alopecia areata. ( Weitzner, JM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Suwanchatchai, W | 1 |
| Tanglertsampan, C | 1 |
| Pengsalae, N | 1 |
| Makornwattana, M | 1 |
| Jacobs, JP | 1 |
| Szpunar, CA | 1 |
| Warner, ML | 1 |
| Veraldi, S | 1 |
| Benelli, C | 1 |
| Pigatto, PD | 1 |
| Ruas, E | 1 |
| Gonçalo, M | 1 |
| Figueiredo, A | 1 |
| Gonçalo, S | 1 |
| Wilson, C | 1 |
| Walkden, V | 1 |
| Powell, S | 1 |
| Shaw, S | 1 |
| Wilkinson, J | 1 |
| Dawber, R | 1 |
| Weitzner, JM | 1 |
| Burnett, JW | 1 |
| Bergfeld, WF | 1 |
| Jordan, WP | 1 |
| Farmer, ER | 1 |
| Uitto, JJ | 1 |
| Civatte, J | 1 |
| Laux, B | 1 |
| Simpson, NB | 1 |
| Vickers, CF | 1 |
| Alomar, A | 1 |
| Smandia, JA | 1 |
| van Joost, T | 1 |
| Price, VH | 1 |
| Tosti, A | 1 |
| Bardazzi, F | 1 |
| De Padova, MP | 1 |
| Caponeri, GM | 1 |
| Melino, M | 1 |
| Veronesi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of 3% Minoxidil Lotion for Beard Enhancement : A Randomized, Double-blind, Placebo-controlled Study[NCT02275832] | Phase 4 | 48 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement : A Randomized, Double-blind, Placebo-controlled Study[NCT02283645] | Phase 4 | 64 participants (Anticipated) | Interventional | 2015-01-31 | Not yet recruiting | ||
| Minoxidil 1% for Eyebrow Enhancement: A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study[NCT01924000] | Phase 4 | 40 participants (Actual) | Interventional | 2013-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for minoxidil and Contact Dermatitis
| Article | Year |
|---|---|
Alopecia areata.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Alopecia Areata; Dermatitis, Contact; Dinitrochloro | 1990 |
5 trials available for minoxidil and Contact Dermatitis
| Article | Year |
|---|---|
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study.
Topics: Adult; Amides; Bimatoprost; Cloprostenol; Dermatitis, Contact; Double-Blind Method; Eyebrows; Female | 2012 |
Use of topical minoxidil therapy for androgenetic alopecia in women.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Alopecia; Dermatitis, Contact; Double-Bli | 1993 |
Contact dermatitis in reaction to 2% topical minoxidil solution.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Contact; Double-Blind Method; Drug Eruptions; | 1991 |
2% topical minoxidil solution in male-pattern baldness: preliminary European results.
Topics: Administration, Cutaneous; Adult; Alopecia; Clinical Trials as Topic; Dermatitis, Contact; Double-Bl | 1987 |
Topical minoxidil in extensive alopecia areata, including 3-year follow-up.
Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Dermatitis, Contact; Double-Bl | 1987 |
7 other studies available for minoxidil and Contact Dermatitis
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Occupational allergic contact dermatitis from minoxidil.
Topics: Dermatitis, Contact; Dermatitis, Occupational; Hand Dermatoses; Humans; Male; Middle Aged; Minoxidil | 1992 |
Allergic contact dermatitis from minoxidil.
Topics: Adult; Dermatitis, Contact; Female; Humans; Male; Minoxidil; Patch Tests | 1992 |
Dermatology days.
Topics: Aging; Alopecia; Androgens; Dermatitis, Contact; Dermatology; Fibrosis; Graft vs Host Disease; Human | 1990 |
Allergic contact dermatitis from minoxidil.
Topics: Alopecia; Dermatitis, Contact; Humans; Male; Minoxidil | 1988 |
[Sensitization for external treatment with minoxidil].
Topics: Administration, Topical; Alopecia; Dermatitis, Contact; Humans; Minoxidil | 1988 |
Contact dermatitis to minoxidil.
Topics: Adult; Alopecia; Dermatitis, Contact; Facial Dermatoses; Humans; Male; Minoxidil; Scalp Dermatoses | 1985 |